1082937-55-0

Basic information

• Product Name: C₂₂H₂₅N₃O₅
• Synonyms: C₂₂H₂₅N₃O₅
• CAS NO: 1082937-55-0
• Molecular Weight: 411.458
• Mol File: 1082937-55-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₂₂H₂₅N₃O₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₂H₂₅N₃O₅(1082937-55-0)
• EPA Substance Registry System: C₂₂H₂₅N₃O₅(1082937-55-0)

Safety Data

• Hazardous Substances Data: 1082937-55-0(Hazardous Substances Data)

Upstream product

• 395639-03-9 bis(1,1-dimethylethyl)(4-nitrophenyl)imidocarbonate 
• 18437-63-3 tert-butyl N-(4-nitrophenyl)carbamate 
• 100-01-6 4-nitro-aniline 
• 71026-66-9 N-(tert-butoxycarbonyl)-1,4-phenylenediamine 
• 161596-47-0 (S)-N-glycidylphthalimide 

Downstream Products

• 1082937-58-3 C₂₃H₂₃N₃O₆ 
• 482308-02-1 N-{[(5S)-3-(4-aminophenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}-5-chloro-2-thiophenecarboxamide 
• 1082937-60-7 C₁₅H₂₁N₃O₄ 
• 1082937-62-9 C₂₀H₂₂ClN₃O₅S 
• 1082937-67-4 C₂₂H₂₇ClN₄O₅S 
• 1159610-29-3 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]-triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide 
• 1159610-49-7 C₂₂H₂₈ClN₅O₅S 
• 1159610-50-0 C₂₃H₃₀ClN₅O₅S 
• 1159610-51-1 C₂₃H₂₉ClN₄O₅S 
• 1159610-52-2 C₂₃H₃₀ClN₅O₅S 
• 1082936-94-4 C₂₃H₂₀ClN₅O₃S 
• 1082936-75-1 C₂₁H₂₁ClN₄O₃S 
• 1082936-73-9 C₂₀H₂₁ClN₄O₃S 
• 1082936-67-1 C₁₉H₁₉ClN₄O₃S 

Relevant articles and documents

FXA INHIBITORS WITH CYCLIC AMIDOXIME OR CYCLIC AMIDRAZONE AS P4 SUBUNIT, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS AND DERIVATIVES THEREOF

The present invention relates to novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group, pharmaceutically acceptable salts thereof, methods for preparing the same and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone group or the pharmaceutically acceptable salts thereof can be effectively used for the treatment of thromboembolism and tumor as an anticoagulant based on the inhibition of factor Xa.

FXA INHIBITORS WITH CYCLIC AMIDINES AS P4 SUBUNIT, PROCESSES FOR THEIR PREPARATIONS, AND PHARMACEUTICAL COMPOSITIONS AND DERIVATIVES THEREOF

The present invention relates to novel oxazolidinone derivatives with cyclic araidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof, and processes for preparing the same, and pharmaceutical compositions comprising the same. The oxazolidinone derivatives with cyclic amidines, and prodrugs, hydrates, solvates, isomers and pharmaceutically acceptable salts thereof can be usefully employed as an anticoagulant for treating thromboembolism and tumors via inhibition of coagulation factor Xa.